Current evidence on the efficacy of Grenz rays therapy for inflammatory skin conditions is very limited and is difficult to assess because reported patient groups are heterogeneous and patient numbers are small. With regard to safety, there is some concern about the risk of skin malignancy in the long term. Therefore, clinicians wishing to use Grenz rays therapy should do so only in research involving controlled trials, closely observed case series and/or contribution to a register. Studies should include clear definitions of treatment indications and quality-of-life measures.
Indications: Grenz rays therapy has been used to treat many benign inflammatory skin conditions that have been unresponsive to conventional treatment, including some forms of eczema and psoriasis. Treatment for inflammatory skin conditions depends on the type, severity and location of the inflammation. Topical…
